Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,813
datasets available to search
ShareScore release 0.9.0
Dataset results
1,813 results for “outcome study”
Inter-Chemical Correlation results for the study: HHEARx2018-2120 (The impact of tobacco smoke exposure and environmental exposures on the pulmonary microbiome and outcomes of critically ill children)
Title: The impact of tobacco smoke exposure and environmental exposures on the pulmonary microbiome and outcomes of critically ill children <br>Species: Homo sapiens <br>Number of samples: 1090 <br>Number of named analytes: 12 <br>Datasource url: https://hheardatacenter.mssm.edu/PublicFile/ViewPublicFile?projectid=42 <br>
Inter-Chemical Correlation results for the study: HHEARx2017-1729 (Air Pollution, Placenta Function, and Birth Outcomes in Los Angeles)
Title: Air Pollution, Placenta Function, and Birth Outcomes in Los Angeles <br>Species: Homo sapiens <br>Number of samples: 450 <br>Number of named analytes: 14 <br>Datasource url: https://hheardatacenter.mssm.edu/PublicFile/ViewPublicFile?projectid=48 <br>
Inter-Chemical Correlation results for the study: HHEARx2016-1534 (A Nested Case-Control Study of Prenatal Exposure to Phthalates and Psychosocial Stress: Adverse Pregnancy Outcomes and the Mediating Role of Placental Function)
Title: A Nested Case-Control Study of Prenatal Exposure to Phthalates and Psychosocial Stress: Adverse Pregnancy Outcomes and the Mediating Role of Placental Function <br>Species: Homo sapiens <br>Number of samples: 5789 <br>Number of named analytes: 17 <br>Datasource url: https://hheardatacenter.mssm.edu/PublicFile/ViewPublicFile?projectid=14 <br>
Inter-Chemical Correlation results for the study: HHEARx2016-1432 (Micronutrient deficiencies, environmental exposures and severe malaria: Risk factors for adverse neurodevelopmental outcomes in Ugandan children)
Title: Micronutrient deficiencies, environmental exposures and severe malaria: Risk factors for adverse neurodevelopmental outcomes in Ugandan children <br>Species: Homo sapiens <br>Number of samples: 1256 <br>Number of named analytes: 51 <br>Datasource url: https://hheardatacenter.mssm.edu/PublicFile/ViewPublicFile?projectid=5 <br>
Inter-Chemical Correlation results for the study: HHEARx2017-1839 (Zika Virus Congenital Health Outcomes and the Impact of Maternal Environmental Exposures)
Title: Zika Virus Congenital Health Outcomes and the Impact of Maternal Environmental Exposures <br>Species: Homo sapiens <br>Number of samples: 2705 <br>Number of named analytes: 10 <br>Datasource url: https://hheardatacenter.mssm.edu/PublicFile/ViewPublicFile?projectid=61 <br>
Flood Hazard Maps and Associated Data for Case Study: Funding rules that promote equity in climate adaptation outcomes
<p>Inundation grids for multiple return periods and multiple scenarios. Please see the underlying study for more details about the methods. The data here can be reproduced following the code and instructions at this repository: https://github.com/CoRE-Lab-UCF/Pollack_et_al_2024/tree/main. Also available here: https://doi.org/10.5281/zenodo.14515896. </p>
Data and Code for "Early complications after mild to moderate ischemic stroke and their impact on 3-months outcome: The prospective Stroke Unit Plus Cohort Study"
<p>This repository consists of the data and code for the publication "Early complications after mild to moderate ischemic stroke and their impact on 3-months outcome: The prospective Stroke Unit Plus Cohort Study"<br> <br> - Analysis code:<br> - Analysis.R<br> - Functions.R</p> <p>- Data:<br> - AnalysisSet in .Rdata, .csv, and .xlsx formats<br> <br> - Variable codebook in .xlsx format</p> <p>Responsibility for the upload lies with Prof. Jan Sobesky, e-mail: j.sobesky@ak-neuss.de<br> For inquiries regarding the data please contact Dr. Vince Madai, e-mail: vince_istvan.madai@bih-charite.de</p>
Repository of Raw Datasets for the Study of Anticoagulation and the Incidence of Stroke and Other Outcomes in Patients with Left Ventricular Thrombus
<p>The optimal duration of anticoagulation in patients with left ventricular thrombus (LVT) is unknown. The data package herein presented contains the data used to assess the effect of duration of anticoagulation in the incidence of stroke in patients with left ventricular thrombus (LVT) in a tertiary hospital. These data includes clinical and demographic information, treatment choices (vitamin K antagonists [VKA] versus direct oral anticoagulants [DOAC]), duration of treatment, reason for interruption of treatment, occurrence of stroke, acute myocardial infarction, bleeding events, thrombus resolution and recurrence, and death.<br> The raw dataset is available upon request to the corresponding author.</p>
Figure 3. from: Visual Parkinson's Disease Rating Scale: A Universal Iconic Questionnaire for Epidemiological Studies in India - Research Ideas and Outcomes 2: e8834 (03 May 2016) https://doi.org/10.3897/rio.2.e8834
Figure 3. - TimelineThis Gantt chart provides an estimate of the relative timing and duration for achieving each of the Aims.
Figure 1. from: Visual Parkinson's Disease Rating Scale: A Universal Iconic Questionnaire for Epidemiological Studies in India - Research Ideas and Outcomes 2: e8834 (03 May 2016) https://doi.org/10.3897/rio.2.e8834
Figure 1. - First pass at a VPDRS static graphicFigure 1 corresponds to the first self-administered MDS-UPDRS question:1.7 SLEEP PROBLEMS.Over the past week, have you had trouble going to sleep at night or staying asleep through the night? Consider how rested you felt after waking up in the morning.0: Normal: No problems.1: Slight: Sleep problems are present but usually do not cause trouble getting a full night of sleep.2: Mild: Sleep problems usually cause some difficulties getting a full night of sleep.3: Moderate: Sleep problems cause a lot of difficulties getting a full night of sleep, but I still usually sleep for more than half the night.4: Severe: I usually do not sleep for most of the night."
Figure 2. from: Visual Parkinson's Disease Rating Scale: A Universal Iconic Questionnaire for Epidemiological Studies in India - Research Ideas and Outcomes 2: e8834 (03 May 2016) https://doi.org/10.3897/rio.2.e8834
Figure 2. - Prototype for the mobile phone appThis screen shows a pre-release version of Node, which will support the VPDRS/UPDRS modules. Here we present a means by which a person administering a questionnaire can securely log into and manipulate patient information locally and through cloud services and lastly an example clinician-administered UPDRS question.
Interim Data and Results for Case Study: Funding rules that promote equity in climate adaptation outcomes
<p>Interim exposure data and results for the published case study. External raw data is available <a href="https://zenodo.org/records/14260630">here</a> and the remaining raw data is generated via code. This is too large to share on Zenodo. There are stochastic aspects in going from raw exposure to interim exposure data and interim exposure data to results, which is why we make the specific interim exposure data and results of the published study available here. Other interim data is not stochastic and can be reproduced following the code reproduction instructions (see https://github.com/abpoll/j40_gc). Please see the underlying study for more details about the methods. The data here can be generally reproduced (not bit-wise) following the code and instructions at this repository: https://zenodo.org/records/14261361.</p> <p> </p> <p>The interim exposure data is named "exp" and the results data is named "results."</p>
The CHASING COVID Cohort Study: A national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA
<p>The Communities, Households and SARS-CoV-2 Epidemiology (CHASING) COVID Cohort Study is a community-based prospective cohort study launched during the upswing of the USA COVID-19 epidemic. The objectives of the cohort study are to: (1) estimate and evaluate determinants of the incidence of SARS-CoV-2 infection, disease and deaths; (2) assess the impact of the pandemic on psychosocial and economic outcomes and (3) assess the uptake of pandemic mitigation strategies. 6740 people are enrolled in the cohort, including participants from all 50 US states, the District of Columbia, Puerto Rico and Guam. Participants are contacted regularly to complete study assessments, including interviews and dried blood spot specimen collection for serologic testing.</p> <p>Datasets are provided in CSV and sas7bdat (with formatting script) file formats.</p>
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
ClinicalTrials.gov study NCT02761187. IPD Sharing: YES. Countries: 15. Publications: 5.
An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairme
ClinicalTrials.gov study NCT01506141. IPD Sharing: YES. Countries: 3. Publications: 3.
Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094
ClinicalTrials.gov study NCT02412787. IPD Sharing: YES. Countries: 7. Publications: 2.
Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.
ClinicalTrials.gov study NCT04774926. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
ClinicalTrials.gov study NCT04567628. IPD Sharing: YES. Countries: 1. Publications: 1.
B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes
ClinicalTrials.gov study NCT03327571. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
ClinicalTrials.gov study NCT03710486. IPD Sharing: YES. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.